Targeting the BH3-interacting domain death agonist to develop mechanistically unique antidepressants

Por Malkesman, O, Austin, DR, Tragon, T, Henter, ID, Reed, JC, Pellecchia, M, Chen, G, Manji, HK
Publicado em 2011

Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania

Por Shaltiel, G, Maeng, S, Malkesman, O, Pearson, B, Schloesser, RJ, Tragon, T, Rogawski, M, Gasior, M, Luckenbaugh, D, Chen, G, Manji, HK
Publicado em 2008

Monoamines, BDNF, Dehydroepiandrosterone, DHEA-Sulfate, and Childhood Depression—An Animal Model Study

Por Malkesman, O., Asaf, T., Shbiro, L., Goldstein, A., Maayan, R., Weizman, A., Kinor, N., Okun, E., Sredni, B., Yadid, G., Weller, A.
Publicado em 2009

Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders

Por Yan, L, Shamir, A, Skirzewski, M, Leiva-Salcedo, E, Kwon, O B, Karavanova, I, Paredes, D, Malkesman, O, Bailey, K R, Vullhorst, D, Crawley, J N, Buonanno, A
Publicado no Mol Psychiatry (2018)